Press Releases

ORIEN Member Presentations at 2023 ASCO Demonstrate Unique Value of Aster Insights’ Data

Aster Insights has announced its participation as a research partner at the American Society of Clinical Oncology (ASCO) Annual Meeting June 2-6, 2023, in Chicago. An oral presentation and three posters will be presented at this year’s ASCO meeting, utilizing the lifetime patient-consented longitudinal clinicogenomic data from the company’s Oncology Research Information Exchange Network® (ORIEN) AVATAR program. These presentations highlight the research partnerships and collaboration of Aster Insights and 18 premier cancer centers that comprise ORIEN. “We are thrilled to be selected for these diverse presentations...

Private AI and Replica Analytics announce partnership to tackle data privacy

Replica Analytics, an Aetion company, is partnering with data privacy software solutions developer Private AI. The partnership is a response to an urgent need for a privacy-preserving solution in healthcare and aims to provide a comprehensive solution for healthcare’s data privacy and security challenges. Replica Analytics’ pioneering software, Replica Synthesis 3.0, generates synthetic structured data, in the place of real data, making healthcare data safe to use in medical research and for other valuable insights. Private AI’s technology accurately detects and removes personally identifiable information from...

Aster Insights Names Dr. Anand Shah as Chief Executive Officer

Aster Insights has announced the appointment of Dr. Anand Shah as chief executive officer, effective immediately. He succeeds Jim Gabriele, who has stepped down from his position. Gabriele and Shah have collaborated closely on a number of strategic, operational, and business development initiatives over the past six months, and they will continue to work together to ensure a smooth leadership transition. As CEO, Dr. Shah will lead the company’s continued growth with a focus on advancing Aster Insights’ national academic research collaborations, developing novel discovery products...

Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research

Twist Bioscience Corporation, a company that offers high-quality synthetic DNA using its silicon platform, along with Aster Insights, has announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620 genes associated with cancer. By integrating the panel into Aster Insights’ AVATAR sequencing program, AsterExome can provide comprehensive analysis in the discovery research market for solid tumor and heme malignancy samples. “This new panel, built with Twist’s design expertise and custom [next-generation...

Clinical ink Announces New Continuous Glucose Monitoring Solution

Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available devices for use in diabetes clinical trials. The solution addresses device connectivity status, providing robust, on-device CGM data collection in both offline and online scenarios with efficient data synchronization management when connected. This integration is facilitated by the recent FDA clearance of commercial CGM devices, which include the Abbott FreeStyle...

RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials

Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested whether researchers asking clinical questions in real-world data (RWD)—data from patients’ day-to-day interactions with the healthcare system—would obtain similar results to findings from randomized clinical trials (RCTs). In cases where clinical trial designs aligned with real patient care processes, the RWE studies and RCTs came to largely similar conclusions. As part of...

Replica Analytics unveils Replica Synthesis 3.0

Replica Analytics, an Aetion company, has released Replica Synthesis 3.0, its privacy- and utility-preserving synthetic data generation software that has been updated with an enhanced user experience. This makes it easier for analysts to train generative models and evaluate their utility and privacy. The company unveiled the latest version of its software during a Privacy Enhancing Technologies (PETs) demonstration at the Privacy Symposium, which attracts data protection experts from around the world to discuss the latest developments in data protection regulations, compliance, and innovative technologies. “There...

M2GEN Rebrands to Aster Insights

Bioinformatics company M2GEN has announced that it is rebranding, changing its name to Aster Insights. As the nexus between patients, researchers, and the life sciences industry, the company’s unique clinical and molecular dataset has enabled new insights for researchers and accelerated target identification and drug discovery. The rebrand reflects both the company’s 15-year history in oncology, genomics, and patient engagement while positioning Aster Insights as the market leader in oncology research and discovery. “Aster [is] derived from the Greek word for ‘star,’ Like the explorers and navigators...

Reimagine Care and The Center for Cancer & Blood Disorders Announce Partnership

Reimagine Care announced that it has partnered with The Center for Cancer & Blood Disorders (CCBD), one of the country’s most respected cancer centers, to offer its home-based supportive care and symptom management program to patients in the Dallas-Fort Worth area. Thousands of CCBD patients will have access to on-demand support from experienced oncology nurses and advanced practitioners via text, phone, and video, along with in-home care when appropriate. This proactive approach is designed to reduce patients’ symptom burden, improve the patient and caregiver experience, and...

Modern Healthcare Recognizes IVX Health in its 2022 Best Places to Work in Healthcare List

For the fourth consecutive year, IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare in 2022. This annual program identifies and honors 150 outstanding companies and organizations in the healthcare industry nationwide, and IVX Health was ranked No. 20 overall in one of its two category designations. “At many of the organizations highlighted, it starts with instilling a sense of balance—and not just the general work-life balance employees crave, but the balance that comes from understanding their...